Abiraterone acetate, a critical therapeutic agent for metastatic castration-resistant prostate cancer (mCRPC), has established itself as a cornerstone in oncology pharmacotherapy. As generic versions continue to expand global access, the demand for abiraterone and its active pharmaceutical ingredient (API) has grown substantially across international markets. For pharmaceutical manufacturers, API producers, and distributors, identifying reliable abiraterone buyers is essential for sustainable business growth. This comprehensive guide presents a detailed overview of the global abiraterone buyers landscape, including verified importer lists, key purchasing markets, procurement channels, and strategic insights for suppliers seeking to connect with legitimate pharmaceutical purchasers worldwide. Global Abiraterone Market Overview The abiraterone market continues to demonstrate robust growth, driven…